Advertisement

Ads Placeholder
Loading...

Bavarian Nordic A/S

BVNKFPNK
Healthcare
Biotechnology
$31.29
$0.00(0.00%)
U.S. Market opens in 5h 2m

Bavarian Nordic A/S (BVNKF) Stock Overview

Explore Bavarian Nordic A/S’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap2.4B
P/E Ratio11.36
EPS (TTM)$2.72
ROE0.11%
Fundamental Analysis

AI Price Forecasts

1 Month$28.71
3 Months$29.62
1 Year Target$32.16

BVNKF Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Bavarian Nordic A/S (BVNKF) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 69.33, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $32.16.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 11.36 and a market capitalization of 2.4B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
2.19%
3-Month Change
6.07%
6-Month Change
-13.11%
Year-to-Date (YTD) Change
6.07%
1-Year Change
51.09%
3-Year Change
5.21%
5-Year Change
-33.30%
All-Time (Max) Change
-9.70%

Contact Information

45 33 26 83 83
Philip Heymans Alle 3, Hellerup, NaN, 2900

Company Facts

16,450 Employees
IPO DateOct 15, 2010
CountryDK
Actively Trading

Frequently Asked Questions